Catalent Agrees To Sell Its Oral Solids Development And Small-Scale Manufacturing Facility In Somerset, NJ; Financial Details Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Catalent has agreed to sell its oral solids development and small-scale manufacturing facility located in Somerset, NJ. The financial details of the transaction have not been disclosed.
October 14, 2024 | 10:02 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Catalent is selling its oral solids development and small-scale manufacturing facility in Somerset, NJ. The financial terms of the deal have not been disclosed.
The sale of the facility could impact Catalent's operational capabilities in oral solids development and manufacturing. However, without financial details, the immediate impact on stock price is uncertain. The move might be part of a strategic shift or optimization of assets.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80